An in silico approach to design a potential drug for Haemophilia A Online publication date: Tue, 23-Jul-2019
by Srishti Munjal; Gaurav Jaisawal; Navodit Goel; Udai Pratap Singh; Ajay Vishwakrma; Abhinav K. Srivastava
International Journal of Computational Biology and Drug Design (IJCBDD), Vol. 12, No. 3, 2019
Abstract: Haemophilia A has been known as a disease since the late 20th century but still no cure has been developed for it. Temporary treatments include new factor replacement therapies delaying the frequency of blood transfusions. In this study, a new prospective drug molecule was designed in silico. Thirteen target proteins were identified from protein databases and their structures observed. Cavities in the protein were determined using Swiss PDB Viewer. Twelve ligands and its isomers were prepared through Molinspiration. Docking between the ligands and target proteins was performed using Molegro Virtual Docker. Docking studies analysed the MolDock and Hydrogen bond score. The most appropriate values were obtained with protein 1SDD and ligand 1. Therefore, Ligand 1 can be proceeded with more studies and developed into a potential drug for Haemophilia A.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Computational Biology and Drug Design (IJCBDD):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com
Our Blog 
Follow us on Twitter 
Visit us on Facebook